US 12,263,228 B2
Lipids and compositions thereof
Matthew G. Stanton, Cambridge, MA (US); Birte Nolting, Cambridge, MA (US); and Andrew Milstead, Cambridge, MA (US)
Assigned to Generation Bio Co., Cambridge, MA (US)
Filed by Generation Bio Co., Cambridge, MA (US)
Filed on Mar. 21, 2024, as Appl. No. 18/612,564.
Application 18/612,564 is a continuation of application No. 18/287,751, previously published as PCT/US2022/025455, filed on Apr. 20, 2022.
Claims priority of provisional application 63/217,869, filed on Jul. 2, 2021.
Claims priority of provisional application 63/176,943, filed on Apr. 20, 2021.
Prior Publication US 2024/0285796 A1, Aug. 29, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 48/00 (2006.01); C07C 229/12 (2006.01)
CPC A61K 48/0033 (2013.01) [A61K 9/5123 (2013.01); A61K 31/7105 (2013.01); A61K 31/711 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); C07C 229/12 (2013.01)] 30 Claims
 
1. A lipid selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.